It has been demonstrated that a high expression of iNOS (inducible NO synthase, one of the isoforms of NOS) correlates with a worse prognosis in ovarian carcinoma [39,40], being associated with more invasive ovarian cancers. Here, NOS2 is linked to ovarian cancer.